Top News in Internal Medicine February 26 2019 (4 of 4) - MD Linx

Top News in Internal Medicine February 26 2019 (4 of 4)  MD Linx

In cancer patients at high risk for venous thromboembolism (VTE), prophylaxis with the direct oral anticoagulant (DOA) rivaroxaban led to a lower incidence of ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more